ResearcherFirst Affiliated Hospital of Soochow UniversityActive in the last 2 years
Haoran Li
Matched on ORCID iD 0000-0001-5108-9218; OpenAlex author ID A5100327706. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. Co-author DOI 10.1016/j.gendis.2025.101870↗
- Long Noncoding RNA LINC00578 Inhibits Ferroptosis in Pancreatic Cancer via Regulating SLC7A11 Ubiquitination. Co-author DOI 10.1155/2023/1744102↗
- Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically resected pancreatic cancer patients. Co-author DOI 10.21037/gs-22-517↗
- Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. First author DOI 10.21037/jgo-21-303↗
- Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.682969↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuchen Tang · 5 shared papers, 2021–2026 · strength 0.88
- Paper SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. DOI 10.1016/j.gendis.2025.101870↗
- Paper Long Noncoding RNA LINC00578 Inhibits Ferroptosis in Pancreatic Cancer via Regulating SLC7A11 Ubiquitination. DOI 10.1155/2023/1744102↗
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Jian Zhou · 4 shared papers, 2021–2026 · strength 0.72
- Paper SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. DOI 10.1016/j.gendis.2025.101870↗
- Paper Long Noncoding RNA LINC00578 Inhibits Ferroptosis in Pancreatic Cancer via Regulating SLC7A11 Ubiquitination. DOI 10.1155/2023/1744102↗
- Paper Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. DOI 10.21037/jgo-21-303↗
- Bin Yi · 3 shared papers, 2021–2026 · strength 0.57
- Paper SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. DOI 10.1016/j.gendis.2025.101870↗
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Paper Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of … DOI 10.3389/fonc.2021.682969↗
- Jian Yang · 2 shared papers, 2022–2026 · strength 0.45
- Paper SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. DOI 10.1016/j.gendis.2025.101870↗
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Yijun Wei · 2 shared papers, 2021–2026 · strength 0.42
- Dongming Zhu · 2 shared papers, 2021–2023 · strength 0.31
- Jun Yao · 1 shared paper, 2026 · strength 0.29
- Ye Li · 2 shared papers, 2021–2022 · strength 0.28
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Paper Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of … DOI 10.3389/fonc.2021.682969↗
- Jian Yang · 1 shared paper, 2023 · strength 0.18
- Jun Yao · 1 shared paper, 2023 · strength 0.18
- Jie Wang · 1 shared paper, 2022 · strength 0.16
- Zixiang Zhang · 1 shared paper, 2022 · strength 0.16
- Chen Zhang · 1 shared paper, 2021 · strength 0.13
- Jian Yang · 1 shared paper, 2021 · strength 0.12
- Peng Du · 1 shared paper, 2021 · strength 0.12
- Dongming Zhu · 1 shared paper, 2021 · strength 0.12
- Yujie Huang · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.